Bsx nyse.

Boston Scientific Corp. (NYSE: BSX) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F. Mahoney -- Chairman and Chief Executive Officer Daniel J. Brennan -- Executive Vice President and Chief Financial Officer Ken Stein -- Vice President, Chief Medical Officer …Web

Bsx nyse. Things To Know About Bsx nyse.

Boston Scientific (NYSE:BSX – Get Free Report) had its price objective upped by research analysts at Canaccord Genuity Group from $60.00 to $64.00 in a research report issued on Monday, Benzinga reports.The firm presently has a “buy” rating on the medical equipment provider’s stock. Canaccord Genuity Group’s price target …WebMARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single ...On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ...1. Confirmed cup and handle pattern on BSX chart Hi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the price target is about 70$. If doesn't will come a market crash, there is a good opportunity, to reach the TP. The price action is supported with the AI hype, that is ...

Tax Effect of Unusual Items. -68,632. -149,867. -20,944. -221,670. -60,210. Get the detailed quarterly/annual income statement for Boston Scientific Corporation (BSX). Find out the revenue ...Ken Griffin raised his stake in Boston Scientific Corporation (NYSE:BSX) by 16% in Q3 2022, holding 14.5 million shares worth $561.25 million, representing 0.12% of the total 13F securities.

73.38%. Get the latest Boston Scientific Corporation (BSX) real-time quote, historical performance, charts, and other financial information to help you make more informed …

1.46b. PB Ratio. 4.353. Bid. 56.11. Bid Size. 2500. VWAP. 55.96737. Ask. 56.12. Ask Size. 200. Exchange. NYSE. Dividend. -. Ex-Div Date. -. Yield. N/A. Div.Find real-time BSX - Boston Scientific Corp stock quotes, company profile, news and forecasts from CNN Business.Nov 28, 2023 · Boston Scientific Corporation (NYSE:BSX), known for its innovative stent technology in heart surgery, has recently ventured into chronic pain management.The company’s strategic acquisition of ... Nov 28, 2023 · 9. Boston Scientific Corporation (NYSE:BSX) Number of Hedge Fund Holders: 69 . Boston Scientific Corporation (NYSE:BSX) makes and sells medical devices.

An analyst from BTIG maintained Boston Scientific (NYSE: BSX) at 'buy' with a price target of $64.00 from a prior price target of $62.00. Prior to this rating, Boston Scientific had 26 buy... Sep 21, 2023 10:05.Web

1.46b. PB Ratio. 4.353. Bid. 56.11. Bid Size. 2500. VWAP. 55.96737. Ask. 56.12. Ask Size. 200. Exchange. NYSE. Dividend. -. Ex-Div Date. -. Yield. N/A. Div.

Boston Scientific Corp (BSX). 56.14 +0.25 (+0.45%) USD | NYSE | Dec 01, 16: ...Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.Boston Scientific Corp. (NYSE:BSX) trade information. Instantly BSX has been showing a green trend so far today with a performance of 0.09% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 53.10 on Friday, 11/03/23 increased the stock’s daily price by 0.98%.1. Confirmed cup and handle pattern on BSX chart Hi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the price target is about 70$. If doesn't will come a market crash, there is a good opportunity, to reach the TP. The price action is supported with the AI hype, that is ...Dec 4, 2023 · Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion. Fintel reports that on April 27, 2023, Barclays maintained coverage of Boston Scientific (NYSE:BSX) with a Overweight recommendation.. Analyst Price Forecast Suggests 7.78% Upside. As of April 24 ...Web

Boston Scientific (NYSE:BSX) topped earnings expectations last week, but I see shares near fair value today while the technical chart is stretched after a massive run and breakout. Buying a dip ...WebA high-level overview of Boston Scientific Corporation (BSX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company …Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.For the full year, Boston Scientific Corporation (NYSE:BSX) lowered its adjusted earnings outlook to a range of $1.71 – $1.74 per share, from its previous guidance between $1.74 – $1.77 per share.Boston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021, and it now seems to be fully valued. Boston Scientific BSX 0.0% saw its stock ...BSX November 24, 2023 NYSE 20 minutes delay $55.63 0.2 (0.361%) Open 55.5 Low 55.2 High 55.68 Data from Refinitiv ...Web

Rock Springs Capital Management LP acquired a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 267,500 shares of the me

29 Nov 2017 ... Is Boston Scientific (NYSE:BSX) a buy? Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, .../PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a... BSX: 51.56 (+0.25%) Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device PR Newswire - Wed Sep 6, 3:00PM CDTWebBoston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept® Intraosseous Nerve Ablation System, a therapy to treat vertebrogenic pain that is a form of chronic low back pain. The Intracept system, a ...WebBoston Scientific Corp (BSX). 56.14 +0.25 (+0.45%) USD | NYSE | Dec 01, 16: ...MARLBOROUGH, Mass., Oct. 6, 2021 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion, subject to closing adjustments. The acquisition will expand the Boston Scientific electrophysiology and ...Boston Scientific Announces Results For Fourth Quarter and Full Year 2021. Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational1 basis...Each major bond market around the world has its own closing hours, but the New York Stock Exchange (NYSE) closes at 4:30 p.m. EST, according to the Financial Web. Bond trading begins on the NYSE at 9:30 a.m. EST.Nov 22, 2023 · In the last trading session, 7.23 million Boston Scientific Corp. (NYSE:BSX) shares changed hands as the company’s beta touched 0.77. With the company’s per share price at $55.32 changed hands at $0.86 or 1.58% during last session, the market valuation stood at $81.04B. BSX’s last price was a ... Nov 27, 2023 · Boston Scientific Corp. (NYSE: BSX)’s stock price has gone rise by 0.22 in comparison to its previous close of 55.43, however, the company has experienced a 1.61% increase in its stock price over the last five trading days. The Motley Fool reported 2023-11-25 that Ozempic could make some medical devices less necessary than before. If that ... Aniversário do 2º CPM. fevereiro 10, 2023. No dia 08 de dezembro de 2022, foi realizada a Solenidade Militar de Entrega de Comando do 2º Colégio da Polícia Militar do Paraná, …

GuruFocus has detected 6 Warning Signs with BSX. Click here to check it out. BSX 30-Year Financial Data. ... (NYSE: TSM), Nvidia’s Data Center division drove this impressive growth, ...

BSX Stock 12 Months Forecast. $60.95. (9.94% Upside) Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.95 with a high forecast of $67.00 and a low forecast of $58.00. The average price target represents a 9.94% change from the last price of $55.44.

Nov 28, 2023 · 9. Boston Scientific Corporation (NYSE:BSX) Number of Hedge Fund Holders: 69 . Boston Scientific Corporation (NYSE:BSX) makes and sells medical devices. Boston Scientific Corporation (NYSE: BSX) was in 58 hedge funds' portfolios at the end of December. The all time high for this statistic is 66. Our calculations also showed that BSX isn't among ...Boston Scientific Corporation Common Stock (BSX) Stock Price, Quote, News & History | Nasdaq MY QUOTES: BSX Edit my quotes Boston Scientific Corporation Common Stock (BSX) 0 Add to...MARLBOROUGH, Mass., Feb. 2, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational 1 basis and 15.1 percent on an organic 2 basis, all compared to the prior year period.Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20! Get market updates, educational videos, webinars, and stock analysis. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.Market Activity. Funds + ETFs. After-Hours Quotes. Investing Lists. News + Insights. P/E & PEG Ratios. ©2021, EDGAR®Online, a division of Donnelley Financial …BSX Stock 12 Months Forecast. $60.95. (9.94% Upside) Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.95 with a high forecast of $67.00 and a low forecast of $58.00. The average price target represents a 9.94% change from the last price of $55.44.Tax Effect of Unusual Items. -68,632. -149,867. -20,944. -221,670. -60,210. Get the detailed quarterly/annual income statement for Boston Scientific Corporation (BSX). Find out the revenue ...TMFAdriaCimino (< 20) Submitted: 2/20/2020 3:59:14 AM : Start Price: $42.31 NYSE:BSX Score: -3.47 Boston Scientific's many devices as well as a new duodenoscope, used in ERCP procedures will drive revenue. The duodenscope is significant because it is the first FDA-cleared single use one.

27 Oct 2023 ... Boston Scientific (NYSE: BSX) announced positive data from a trial of its Agent drug-coated balloon (DCB).BSX Stock 12 Months Forecast. $60.95. (9.94% Upside) Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.95 with a high forecast of $67.00 and a low forecast of $58.00. The average price target represents a 9.94% change from the last price of $55.44.28 Jan 2016 ... MARLBOROUGH, Mass. and NEW YORK; Jan. 28, 2016 - Boston Scientific Corporation (NYSE: BSX) and Accenture (NYSE: ACN) have developed a ...Boston Scientific Corporation (NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany Participants. Lauren Tengler - Vice President, Investor Relations. Mike Mahoney ...Instagram:https://instagram. ring insurance comparisonschwab best mutual fundsmicrosoft dividend datenvos stock forecast Boston Scientific Corporation (BSX) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M 55.88 -0.01 (-0.03%) As of 02:28PM EST. Market open. 1d 5d 1m 6m …Boston Scientific Corp. (NYSE:BSX) trade information. Instantly BSX has been showing a green trend so far today with a performance of 0.09% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 53.10 on Friday, 11/03/23 increased the stock’s daily price by 0.98%. communication etfsmoulin rouge aaron tveit Boston Scientific Corp. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View BSX financial statements in full.Boston Scientific Corp stock price (BSX) NYSE: BSX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Boston Scientific Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. v stock forecast NYSE:BSX Discounted Cash Flow December 4th 2023 Important Assumptions . The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them.On October 27, investment advisory Canaccord maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) stock and lowered the price target to $60 from $64, appreciating the strong ...MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.